Robin Meyer

Robin Meyer serves as a procurement professional within the CDC Office of Acquisition Services, supporting the agency’s mission to safeguard public health through strategic acquisition of critical scientific and diagnostic capabilities. Responsible for managing complex contracting actions, Robin specializes in procuring laboratory instrumentation, in-vitro diagnostic systems, and biomedical research services that enable infectious disease surveillance, rapid response, and data-driven public health operations. Their work directly supports CDC’s scientific infrastructure, ensuring timely access to cutting-edge analytical tools and testing services essential for national health security. Robin maintains sustained relationships with leading providers in the public health and life sciences sectors, including General Dynamics Information Technology, GlaxoSmithKline, MRIGLOBAL, and Cepheid. These partnerships reflect a focus on high-capacity, mission-critical vendors capable of delivering advanced diagnostic platforms, biosafety-compliant testing solutions, and scalable laboratory services. The contracting patterns demonstrate a preference for established industry leaders with proven track records in regulatory compliance, quality assurance, and rapid deployment under public health emergencies. Set-aside preferences are heavily weighted toward unrestricted competitions, with 91.7% of awards issued without socioeconomic set-asides, reflecting the technical complexity and scale of required capabilities. A modest 8.3% of contracts are awarded under total small business set-asides, indicating selective but intentional support for qualified small businesses when market conditions and technical requirements align. This pattern underscores a balance between mission-critical performance needs and broader socioeconomic objectives. The procurement portfolio is dominated by NAICS 334516 (Analytical Laboratory Instrument Manufacturing), with significant activity in in-vitro diagnostic substance manufacturing and testing laboratory services. Robin’s expertise centers on acquiring precision instruments for pathogen detection, molecular diagnostics, and bioresearch infrastructure, demonstrating deep familiarity with FDA-regulated medical devices, CLIA-compliant testing environments, and biosafety-level 3/4 operational requirements. Their work ensures CDC’s laboratories remain equipped with the most advanced tools for national and global health defense.